Jennifer E. Cook's Net Worth
$2 Million
Who is Jennifer E. Cook?
Jennifer E. Cook has an estimated net worth of $2 Million. This is based on reported shares across multiple companies, which include BridgeBio Pharma, Inc., Jazz Pharmaceuticals plc, and Denali Therapeutics Inc..
SEC CIK
Jennifer E. Cook's CIK is 0001754371
Past Insider Trading and Trends
2021 was Jennifer E. Cook's most active year for acquiring shares with 8 total transactions. Jennifer E. Cook's most active month to acquire stocks was the month of May. 2021 was Jennifer E. Cook's most active year for disposing of shares, totalling 3 transactions. Jennifer E. Cook's most active month to dispose stocks was the month of November. 2020 saw Jennifer E. Cook paying a total of $0.00 for 134,434 shares, this is the most they've acquired in one year. In 2023 Jennifer E. Cook cashed out on 1,658 shares for a total of $221,189.79, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BridgeBio Pharma, Inc. (BBIO) Snapshot price: $30.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +100.00% | 3.58K |
—
|
—
| 7.15K |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
∞
| 3.58K |
—
|
—
| 3.58K |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $107.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.71% | -417.00 |
$119.27 | -$49,735.59 | 6.89K |
Dec 4
| |||
Form 4
| +33.52% | 1.83K |
$138.16 | -$171,454.20 | 7.3K |
Aug 11 - Aug 14
| |||
Form 4
| -7.13% | -420.00 |
$154.68 | -$64,965.56 | 5.47K |
Dec 2
| |||
Form 4
| +33.31% | 1.47K |
$152.32 | -$165,879.42 | 5.89K |
Aug 5 - Aug 8
| |||
Form 4
| -8.62% | -417.00 |
$121.30 | -$50,582.10 | 4.42K |
Dec 2
| |||
Form 4
| +86.72% | 2.25K |
—
|
—
| 4.84K |
Jul 29
| |||
Form 4
|
∞
| 2.59K |
—
|
—
| 2.59K |
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Denali Therapeutics Inc. (DNLI) Snapshot price: $25.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.78% | -1.46K |
$21.73 | -$31,682.34 | 20.04K |
Scheduled
|
Jun 6
| ||
Form 4
| +38.42% | 5.97K |
—
|
—
| 21.5K |
May 31
| |||
Form 4
| +37.27% | 4.22K |
—
|
—
| 15.53K |
Jun 1
| |||
Form 4
| +112.37% | 5.99K |
—
|
—
| 11.31K |
Jun 2
| |||
Form 4
| +63.76% | 2.07K |
—
|
—
| 5.33K |
Jun 2
| |||
Form 4
|
∞
| 3.25K |
—
|
—
| 3.25K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||